2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

被引：425

作者：

Vansteenkiste, J. ^{[1
]}

Crino, L. ^{[2
]}

Dooms, C. ^{[1
]}

Douillard, J. Y. ^{[3
]}

Faivre-Finn, C. ^{[4
]}

Lim, E. ^{[5
,6
]}

Rocco, G. ^{[7
]}

Senan, S. ^{[8
]}

Van Schil, P. ^{[9
]}

Veronesi, G. ^{[10
]}

Stahel, R. ^{[11
]}

Peters, S. ^{[12
]}

Felip, E. ^{[13
]}

机构：

[1] Univ Hosp KU Leuven, Resp Oncol Unit Pulmonol, Leuven, Belgium

[2] Azienda Osped Perugia, Santa Maria Della Misericordia Hosp, Dept Oncol, Perugia, Italy

[3] Integrated Ctr Oncol R Gauducheau, Dept Med Oncol, St Herblain, France

[4] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England

[5] Univ London Imperial Coll Sci Technol & Med, London, England

[6] Royal Brompton Hosp, Acad Div Thorac Surg, London SW3 6LY, England

[7] Pascale Fdn, IRCCS, Natl Canc Inst, Dept Thorac Surg & Oncol, Naples, Italy

[8] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands

[9] Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Antwerp, Belgium

[10] European Inst Oncol, Dept Thorac Surg, Milan, Italy

[11] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland

[12] CHU Vaudois, Dept Oncol, CH-1011 Lausanne, Switzerland

[13] Vall DHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷 / 08期

关键词：

ESMO; consensus; lung cancer; non-small-cell lung cancer; early disease; STEREOTACTIC BODY RADIOTHERAPY; VINORELBINE PLUS CISPLATIN; ASSISTED THORACIC-SURGERY; CARDIAC RISK INDEX; ABLATIVE RADIOTHERAPY; PULMONARY NODULES; INTERNATIONAL ASSOCIATION; ADJUVANT VINORELBINE; EMISSION-TOMOGRAPHY; SUBLOBAR RESECTION;

D O I：

10.1093/annonc/mdu089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on early-stage disease.

引用

页码：1462 / 1474

页数：13

共 83 条

[1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].

Aberle, Denise R. ;

Adams, Amanda M. ;

Berg, Christine D. ;

Black, William C. ;

Clapp, Jonathan D. ;

Fagerstrom, Richard M. ;

Gareen, Ilana F. ;

Gatsonis, Constantine ;

Marcus, Pamela M. ;

Sicks, JoRean D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409

[2]

[Anonymous], 2022, CLIN PRACTICE GUIDEL

[3] Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning [J].

Ashraf, H. ;

Dirksen, A. ;

Loft, A. ;

Bertelsen, A. K. ;

Bach, K. S. ;

Hansen, H. ;

Pedersen, J. H. ;

Mortensen, J. .

THORAX, 2011, 66 (04) :315-319

[4] Benefits and Harms of CT Screening for Lung Cancer A Systematic Review [J].

Bach, Peter B. ;

Mirkin, Joshua N. ;

Oliver, Thomas K. ;

Azzoli, Christopher G. ;

Berry, Donald A. ;

Brawley, Otis W. ;

Byers, Tim ;

Colditz, Graham A. ;

Gould, Michael K. ;

Jett, James R. ;

Sabichi, Anita L. ;

Smith-Bindman, Rebecca ;

Wood, Douglas E. ;

Qaseem, Amir ;

Detterbeck, Frank C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2418-2429

[5] Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival [J].

Battafarano, RJ ;

Meyers, BF ;

Guthrie, TJ ;

Cooper, JD ;

Patterson, GA .

ANNALS OF THORACIC SURGERY, 2002, 74 (04) :988-993

[6] Sublobar Resection A Movement from the Lung Cancer Study Group [J].

Blasberg, Justin D. ;

Pass, Harvey I. ;

Donington, Jessica S. .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) :1583-1593

[7] Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer [J].

Bongers, Eva M. ;

Haasbeek, Cornelis J. A. ;

Lagerwaard, Frank J. ;

Slotman, Ben J. ;

Senan, Suresh .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) :2052-2057

[8] Time to adjuvant chemotherapy and survival in non-small cell lung cancer A Population-Based Study [J].

Booth, Christopher M. ;

Shepherd, Frances A. ;

Peng, Yingwei ;

Darling, Gail ;

Li, Gavin ;

Kong, Weidong ;

Biagi, James J. ;

Mackillop, William J. .

CANCER, 2013, 119 (06) :1243-1250

[9] New Territory Surgical Salvage for Stereotactic Body Radiation Therapy Failures in Lung Cancer [J].

Bradley, Jeffrey .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) :1879-1880

[10] ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) [J].

Brunelli, A. ;

Charloux, A. ;

Bolliger, C. T. ;

Rocco, G. ;

Sculier, J-P. ;

Varela, G. ;

Licker, M. ;

Ferguson, M. K. ;

Faivre-Finn, C. ;

Huber, R. M. ;

Clini, E. M. ;

Win, T. ;

De Ruysscher, D. ;

Goldman, L. .

EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (01) :17-41

← 1 2 3 4 5 6 7 8 9 →